These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4139202)

  • 1. The antibody response to myelin basic protein (BP) in Lewis rats: the effect of time, dosage of BP, and dosage of Mycobacterium butyricum.
    Day ED; Pitts OM
    J Immunol; 1974 Dec; 113(6):1958-67. PubMed ID: 4139202
    [No Abstract]   [Full Text] [Related]  

  • 2. The antibody responses to myelin basic protein (BP) in Lewis rats: the effects of Bordetella pertussis.
    Pitts OM; Varitek VA; Day ED
    J Immunol; 1975 Oct; 115(4):1114-6. PubMed ID: 51876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody response to myelin basic protein in Lewis and Fischer rats as followed by a sodium sulfate method of radioimmunoassay.
    Day ED; Wexler MA
    J Immunol; 1974 Dec; 113(6):1952-7. PubMed ID: 4139201
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of water-soluble adjuvant fraction from "Mycobacterium smegmatis" with encephalitogenic basic protein to induce autoimmune experimental allergic encephalomyelitis in guinea pigs (author's transl)].
    Lebar R; Voisin GA
    Ann Immunol (Paris); 1974 Nov; 125(6):911-6. PubMed ID: 4143099
    [No Abstract]   [Full Text] [Related]  

  • 5. Reaginic antibody in experimental allergic encephalomyelitis. I. Characterization of heat-labile skin-fixing antibody.
    Moore MJ; Behan PO; Kies MW; Matthews JM
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):119-32. PubMed ID: 4140559
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1981 Jul; 127(1):16-20. PubMed ID: 6165759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
    Killen JA; Swanborg RH
    J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
    Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular events in protein tolerant inbred rats. I. The fate of thoracic duct lymphocytes and memory cells during tolerance induction to human serum albumin.
    Bell EB; Shand FL
    Eur J Immunol; 1973 May; 3(5):259-67. PubMed ID: 4357185
    [No Abstract]   [Full Text] [Related]  

  • 11. Time relationships between injection of antigen and adjuvant. II. Immunosuppression induced by Bordetella pertussis vaccine when given before secondary antigenic stimulation.
    Finger H; Bartoschek M; Emmerling P
    Pathol Microbiol (Basel); 1972; 38(2):93-102. PubMed ID: 4337644
    [No Abstract]   [Full Text] [Related]  

  • 12. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis.
    Lobell A; Weissert R; Eltayeb S; Svanholm C; Olsson T; Wigzell H
    J Immunol; 1999 Nov; 163(9):4754-62. PubMed ID: 10528174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental autoimmune encephalomyelitis in Lewis rats: IFN-beta acts as a tolerogenic adjuvant for induction of neuroantigen-dependent tolerance.
    Mannie MD; Abbott DJ; Blanchfield JL
    J Immunol; 2009 May; 182(9):5331-41. PubMed ID: 19380780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged suppression of experimental allergic encephalomyelitis in the Lewis rats: the effect of lipopolysaccharides.
    Raziuddin S; Morrison DC
    J Immunol; 1982 Mar; 128(3):1486-9. PubMed ID: 6173441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of macrophage-myelin basic protein interaction in the induction of experimental allergic encephalomyelitis in Lewis rats.
    Carbone AM; Ovadia H; Paterson PY
    J Immunol; 1983 Sep; 131(3):1263-7. PubMed ID: 6193182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response of the nude (athymic) rat to actively induced and adoptively transferred experimental allergic encephalomyelitis.
    Hinrichs DJ; Humphres RC
    J Immunol; 1983 Jul; 131(1):4-5. PubMed ID: 6190918
    [No Abstract]   [Full Text] [Related]  

  • 18. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism.
    Vandenbark AA; Celnik B; Vainiene M; Miller SD; Offner H
    J Immunol; 1995 Dec; 155(12):5861-7. PubMed ID: 7499876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of myelin basic protein reactive T cells from spinal cords of Lewis rats with autoimmune encephalomyelitis.
    Burns J; Rosenzweig A; Zweiman B; Moskovitz A; Lisak R
    J Immunol; 1984 Jun; 132(6):2690-2. PubMed ID: 6202757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of encephalitogenic and immunodominant epitopes of guinea pig myelin basic protein (Gp-BP) in Lewis rats tolerized neonatally with Gp-BP or Gp-BP peptides.
    Vandenbark AA; Vainiene M; Celnik B; Hashim GA; Buenafe A; Offner H
    J Immunol; 1994 Jul; 153(2):852-61. PubMed ID: 7517426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.